Literature DB >> 15585588

Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins.

Kirsi Hannele Pietiläinen1, Aila Rissanen, Jaakko Kaprio, Sari Mäkimattila, Anna-Maija Häkkinen, Jukka Westerbacka, Jussi Sutinen, Satu Vehkavaara, Hannele Yki-Järvinen.   

Abstract

We determined whether acquired obesity is associated with increases in liver or intra-abdominal fat or impaired insulin sensitivity by studying monozygotic (MZ) twin pairs discordant and concordant for obesity. We studied nineteen 24- to 27-yr-old MZ twin pairs, with intrapair differences in body weight ranging from 0.1 to 24.7 kg [body mass index (BMI) range 20.0-33.9 kg/m2], identified from a population-based FinnTwin16 sample. Fat distribution was determined by magnetic resonance imaging, percent body fat by dual-energy X-ray absorptiometry, liver fat by proton spectroscopy, insulin sensitivity by measuring the fasting insulin concentration, and whole body insulin sensitivity by the euglycemic insulin clamp technique. Intrapair differences in BMI were significantly correlated with those in intra-abdominal fat (r = 0.82, P < 0.001) and liver fat (r = 0.57, P = 0.010). Intrapair differences in fasting insulin correlated with those in subcutaneous abdominal (r = 0.60, P = 0.008), intra-abdominal (r = 0.75, P = 0.0001) and liver (r = 0.49, P = 0.048) fat. Intrapair differences in whole body insulin sensitivity correlated with those in subcutaneous abdominal (r = -0.72, P = 0.001) and intra-abdominal (r = -0.55, P = 0.015) but not liver (r = -0.20, P = 0.20) fat. We conclude that acquired obesity is associated with increases in intra-abdominal and liver fat and insulin resistance, independent of genetic factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15585588     DOI: 10.1152/ajpendo.00381.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  23 in total

1.  Inherited susceptibility to non-alcoholic fatty liver disease.

Authors:  R J F Loos; D B Savage
Journal:  Diabetologia       Date:  2009-03-25       Impact factor: 10.122

Review 2.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 3.  NAFLD/NASH in patients with type 2 diabetes and related treatment options.

Authors:  M G Radaelli; F Martucci; S Perra; S Accornero; G Castoldi; G Lattuada; G Manzoni; G Perseghin
Journal:  J Endocrinol Invest       Date:  2017-11-30       Impact factor: 4.256

4.  Metabolome and fecal microbiota in monozygotic twin pairs discordant for weight: a Big Mac challenge.

Authors:  Isabel Bondia-Pons; Johanna Maukonen; Ismo Mattila; Aila Rissanen; Maria Saarela; Jaakko Kaprio; Antti Hakkarainen; Jesper Lundbom; Nina Lundbom; Tuulia Hyötyläinen; Kirsi H Pietiläinen; Matej Orešič
Journal:  FASEB J       Date:  2014-05-20       Impact factor: 5.191

5.  Neonatal overfeeding causes higher adrenal catecholamine content and basal secretion and liver dysfunction in adult rats.

Authors:  E P S Conceição; E G Moura; I H Trevenzoli; N Peixoto-Silva; C R Pinheiro; V Younes-Rapozo; E Oliveira; P C Lisboa
Journal:  Eur J Nutr       Date:  2012-09-29       Impact factor: 5.614

6.  Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins.

Authors:  Jarna C Hannukainen; Pirjo Nuutila; Ronald Borra; Borra Ronald; Jaakko Kaprio; Urho M Kujala; Tuula Janatuinen; Olli J Heinonen; Jukka Kapanen; Tapio Viljanen; Merja Haaparanta; Tapani Rönnemaa; Riitta Parkkola; Juhani Knuuti; Kari K Kalliokoski
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

7.  Adiposity and Cardiometabolic Risk in Children With and Without Antipsychotic Drug Treatment.

Authors:  Ginger E Nicol; Lisa de Las Fuentes; Amy E Riek; Carlos Bernal-Mizrachi; Eric J Lenze; J Phillip Miller; Julia A Schweiger; Michael D Yingling; Vincent J Huang; David J Dixon; Charles H Hennekens; John W Newcomer
Journal:  J Clin Endocrinol Metab       Date:  2015-07-17       Impact factor: 5.958

Review 8.  Viewpoints on the way to a consensus session: where does insulin resistance start? The liver.

Authors:  Gianluca Perseghin
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

Review 9.  Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease.

Authors:  Kristina Blaslov; Tomislav Bulum; Karin Zibar; Lea Duvnjak
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 10.  Metabolically healthy and unhealthy obese--the 2013 Stock Conference report.

Authors:  D Samocha-Bonet; V D Dixit; C R Kahn; R L Leibel; X Lin; M Nieuwdorp; K H Pietiläinen; R Rabasa-Lhoret; M Roden; P E Scherer; S Klein; E Ravussin
Journal:  Obes Rev       Date:  2014-07-25       Impact factor: 9.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.